Total Holdings
262
Portfolio diversification across 262 positions
BIB
(NASDAQ)ProShares Ultra Nasdaq Biotechnology
$99.04-- (--)
Loading... - Market loading
BIB ETF Holdings: ProShares Ultra Nasdaq Biotechnology
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$69.83M
Total fund assets
Expense Ratio
0.95%
Annual management fee
Fund Issuer
ProShares
Nasdaq Stock Market
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 43 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Gilead Sciences, Inc | Stock | 4.86% |
| 2 |  | Vertex Pharmaceuticals Incorporated | Stock | 4.79% |
| 3 |  | Amgen Inc. | Stock | 4.71% |
| 4 |  | Regeneron Pharmaceuticals, Inc | Stock | 3.85% |
| 5 |  | Alnylam Pharmaceuticals, Inc | Stock | 2.10% |
| 6 |  | Revolution Medicines, Inc. | Stock | 1.59% |
| 7 |  | Insmed Incorporated | Stock | 1.58% |
| 8 |  | Biogen Inc. | Stock | 1.47% |
| 9 |  | United Therapeutics Corporation | Stock | 1.32% |
| 10 |  | Illumina, Inc. | Stock | 1.28% |
| 11 |  | argenx SE | Stock | 1.27% |
| 12 |  | Royalty Pharma plc | Stock | 1.19% |
| 13 |  | Moderna, Inc. | Stock | 1.12% |
| 14 |  | Roivant Sciences Ltd. | Stock | 1.11% |
| 15 |  | Incyte Corporation | Stock | 1.02% |
| 16 |  | Viatris Inc | Stock | 0.94% |
| 17 |  | Guardant Health, Inc. | Stock | 0.85% |
| 18 |  | Neurocrine Biosciences, Inc. | Stock | 0.80% |
| 19 |  | Ascendis Pharma A/S | Stock | 0.73% |
| 20 |  | Summit Therapeutics PLC | Stock | 0.72% |
| 21 |  | BridgeBio Pharma, Inc | Stock | 0.70% |
| 22 |  | Jazz Pharmaceuticals plc | Stock | 0.69% |
| 23 |  | Ionis Pharmaceuticals, Inc | Stock | 0.66% |
| 24 |  | Medpace Holdings, Inc | Stock | 0.64% |
| 25 |  | Exelixis, Inc | Stock | 0.61% |
| 26 |  | Madrigal Pharmaceuticals, Inc | Stock | 0.61% |
| 27 |  | Axsome Therapeutics, Inc | Stock | 0.60% |
| 28 |  | BioNTech SE | Stock | 0.57% |
| 29 |  | Sanofi | Stock | 0.56% |
| 30 |  | Arrowhead Pharmaceuticals, Inc | Stock | 0.55% |
| 31 |  | BioMarin Pharmaceutical Inc | Stock | 0.54% |
| 32 | B BGNE | BeiGene, Ltd | Stock | 0.50% |
| 33 |  | Cytokinetics, Incorporated | Stock | 0.50% |
| 34 |  | Tempus AI, Inc. Class A Common Stock | Stock | 0.50% |
| 35 |  | Praxis Precision Medicines, Inc | Stock | 0.49% |
| 36 |  | Krystal Biotech, Inc | Stock | 0.44% |
| 37 |  | Vaxcyte, Inc | Stock | 0.42% |
| 38 | N NK | NantKwest Inc | Stock | 0.41% |
| 39 |  | Halozyme Therapeutics, Inc | Stock | 0.41% |
| 40 | P PINK:AAVXF | ABIVAX Société Anonyme | Stock | 0.40% |
| 41 |  | Nuvalent Inc | Stock | 0.39% |
| 42 |  | Kymera Therapeutics, Inc | Stock | 0.36% |
| 43 |  | Mirum Pharmaceuticals Inc | Stock | 0.34% |
Frequently Asked Questions About ProShares Ultra Nasdaq Biotechnology Holdings
What are the top holdings in BIB?
ProShares Ultra Nasdaq Biotechnology (BIB) holds 262 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is BIB's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review BIB's holdings table to analyze concentration risk.
What is BIB's sector allocation?
The Sector Allocation chart shows how BIB distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does BIB invest in?
BIB's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is BIB ETF?
BIB's diversification can be assessed by reviewing its 262 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.